Free Trial

Expensify (EXFY) Competitors

Expensify logo
$1.92 +0.02 (+0.79%)
As of 12:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EXFY vs. DAVA, WEAV, DOMO, OSPN, DH, ECX, LZMH, CANG, CCSI, and BLZE

Should you be buying Expensify stock or one of its competitors? The main competitors of Expensify include Endava (DAVA), Weave Communications (WEAV), Domo (DOMO), Onespan (OSPN), Definitive Healthcare (DH), ECARX (ECX), LZ Technology (LZMH), Cango (CANG), Consensus Cloud Solutions (CCSI), and Backblaze (BLZE). These companies are all part of the "computer software" industry.

Expensify vs. Its Competitors

Endava (NYSE:DAVA) and Expensify (NASDAQ:EXFY) are both small-cap computer software companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

62.2% of Endava shares are owned by institutional investors. Comparatively, 68.4% of Expensify shares are owned by institutional investors. 18.8% of Endava shares are owned by insiders. Comparatively, 17.3% of Expensify shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Endava has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Comparatively, Expensify has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500.

Endava has higher revenue and earnings than Expensify. Expensify is trading at a lower price-to-earnings ratio than Endava, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Endava$772.26M0.73$27.45M$0.4521.34
Expensify$139.24M1.11-$10.06M-$0.16-11.97

Endava has a net margin of 2.73% compared to Expensify's net margin of -10.72%. Endava's return on equity of 5.56% beat Expensify's return on equity.

Company Net Margins Return on Equity Return on Assets
Endava2.73% 5.56% 3.62%
Expensify -10.72%-12.02%-8.52%

In the previous week, Expensify had 1 more articles in the media than Endava. MarketBeat recorded 3 mentions for Expensify and 2 mentions for Endava. Expensify's average media sentiment score of 1.87 beat Endava's score of 0.47 indicating that Expensify is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Endava
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Expensify
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Endava currently has a consensus target price of $20.78, suggesting a potential upside of 116.35%. Expensify has a consensus target price of $4.00, suggesting a potential upside of 108.88%. Given Endava's higher possible upside, equities analysts clearly believe Endava is more favorable than Expensify.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Endava
0 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.30
Expensify
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Endava beats Expensify on 10 of the 16 factors compared between the two stocks.

Get Expensify News Delivered to You Automatically

Sign up to receive the latest news and ratings for EXFY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXFY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EXFY vs. The Competition

MetricExpensifyFinancial Transaction Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$154.25M$33.19B$26.19B$10.26B
Dividend YieldN/A2.22%2.74%4.60%
P/E Ratio-11.9739.2326.7026.36
Price / Sales1.1121.951,080.62167.32
Price / CashN/A18.1625.8729.90
Price / Book1.157.247.776.29
Net Income-$10.06M$1.12B$198.10M$270.30M
7 Day Performance-1.29%6.65%3.44%1.95%
1 Month Performance6.39%9.79%19.81%6.14%
1 Year Performance-14.89%32.34%48.97%27.92%

Expensify Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EXFY
Expensify
2.789 of 5 stars
$1.92
+0.8%
$4.00
+108.9%
-24.6%$154.25M$139.24M-11.97140Positive News
DAVA
Endava
4.6402 of 5 stars
$10.02
-1.6%
$20.78
+107.4%
-71.8%$600.94M$999.23M22.2612,085
WEAV
Weave Communications
3.4004 of 5 stars
$7.90
+1.9%
$15.10
+91.1%
-26.9%$597.03M$204.31M-19.75890Positive News
DOMO
Domo
3.7097 of 5 stars
$15.07
+3.1%
$17.00
+12.8%
+135.8%$588.24M$317.04M-7.77920
OSPN
Onespan
4.9235 of 5 stars
$15.60
+2.6%
$19.67
+26.1%
+0.1%$582.92M$243.18M10.33790Positive News
DH
Definitive Healthcare
1.6802 of 5 stars
$4.15
+3.8%
$4.73
+14.1%
-8.8%$572.57M$252.20M-1.57970Positive News
ECX
ECARX
2.9555 of 5 stars
$1.58
+2.6%
$3.20
+102.5%
+4.0%$570.92M$761.90M-4.391,918Positive News
Short Interest ↓
LZMH
LZ Technology
N/A$3.42
-6.0%
N/AN/A$546MN/A0.0067
CANG
Cango
2.3657 of 5 stars
$5.52
+9.4%
$8.00
+45.1%
+198.4%$523.07M$110.21M-1.912,350High Trading Volume
CCSI
Consensus Cloud Solutions
2.5316 of 5 stars
$27.15
+1.3%
$27.40
+0.9%
+24.4%$508.77M$350.38M6.54460Positive News
BLZE
Backblaze
1.9613 of 5 stars
$9.14
+5.1%
$10.07
+10.2%
+58.3%$491.55M$127.63M-10.27270Positive News

Related Companies and Tools


This page (NASDAQ:EXFY) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners